Surprisingly, a study suggested that elevated ECM stiffness can independently contribute to the aggressiveness and recurrence of GBM and predict a worse outcome of glioma patients via bypassing the isocitrate dehydrogenase 1 (IDH1) mutational protection [15]. The gene discussed is IDH1; the disease is central nervous system cancer.